KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Inventory Average: 2012-2025

Historic Inventory Average for Supernus Pharmaceuticals (SUPN) over the last 13 years, with Sep 2025 value amounting to $61.7 million.

  • Supernus Pharmaceuticals' Inventory Average fell 6.59% to $61.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.7 million, marking a year-over-year decrease of 6.59%. This contributed to the annual value of $65.9 million for FY2024, which is 22.05% down from last year.
  • According to the latest figures from Q3 2025, Supernus Pharmaceuticals' Inventory Average is $61.7 million, which was up 32.08% from $46.7 million recorded in Q2 2025.
  • Supernus Pharmaceuticals' Inventory Average's 5-year high stood at $91.3 million during Q1 2023, with a 5-year trough of $46.7 million in Q2 2025.
  • Over the past 3 years, Supernus Pharmaceuticals' median Inventory Average value was $71.6 million (recorded in 2024), while the average stood at $71.2 million.
  • In the last 5 years, Supernus Pharmaceuticals' Inventory Average soared by 93.06% in 2021 and then slumped by 34.76% in 2025.
  • Quarterly analysis of 5 years shows Supernus Pharmaceuticals' Inventory Average stood at $73.1 million in 2021, then grew by 19.57% to $87.4 million in 2022, then declined by 7.91% to $80.4 million in 2023, then fell by 26.49% to $59.1 million in 2024, then decreased by 6.59% to $61.7 million in 2025.
  • Its Inventory Average stands at $61.7 million for Q3 2025, versus $46.7 million for Q2 2025 and $51.9 million for Q1 2025.